|
Issue |
Title |
|
No 1 (2024) |
Systematic analysis of the pharmacology of myoinositol and D-chiroinositola |
Abstract
PDF (Rus)
|
T. E. Bogacheva, O. A. Gromova, I. Yu. Torshin |
|
No 3 (2017) |
Brain-derived neurotrophic factor and its low-molecular mimetics |
Abstract
PDF (Rus)
|
T. A. Gudasheva, A. V. Tarasiuk, P. Yu. Povarnina, S. B. Seredenin |
|
No 3 (2017) |
Animal models of depression |
Abstract
PDF (Rus)
|
T. L. Garibova, V. A. Kraineva, T. A. Voronina |
|
No 1 (2013) |
Pharmacokinetics of antisense oligonucleotide drugs |
Abstract
PDF (Rus)
|
M. R. Khaitov, V. V. Smirnov |
|
No 2 (2013) |
Study the pharmacokinetics and bioavailability in the creation of new original drugs peptide structures and their optimum dosage forms |
Abstract
PDF (Rus)
|
E. V. Ivannikova, V. P. Zherdev, S. S. Boyko, E. V. Blynskaya, K. G. Turchinskaya, K. V. Alekseev |
|
No 1 (2016) |
Effects of the high-molecular excipients on optimization of the pharmacokinetic properties of drugs |
Abstract
PDF (Rus)
|
P. . Bochkov, G. . Kolyvanov, A. . Litvin, V. . Zherdev, R. . Shevchenko |
|
No 1 (2016) |
Factors, effecting on drug bioavailability |
Abstract
PDF (Rus)
|
P. . Bochkov, R. . Shevchenko, A. . Litvin, G. . Kolyvanov, V. . Zherdev |
|
No 1 (2016) |
Pharmacokinetic interaction of drugs, the metabolisable cytochrome P450 isoenzyme CYP2C9 |
Abstract
PDF (Rus)
|
O. G. Gribakina, G. B. Kolyvanov, A. A. Litvin, A. O. Viglinskaya, V. P. Zherdev |
|
No 1 (2016) |
Aspects of «Cocktail» cytochrome P450 activity determination methods application with the view of drug treatment rationalization |
Abstract
PDF (Rus)
|
E. . Egorenkov, V. . Smirnov, A. . Litvin, G. . Kolyvanov, G. . Ramenskaya |
|
No 2 (2016) |
Food-drug interactions: genotoxicological aspects |
Abstract
PDF (Rus)
|
A. D. Durnev |
|
1 - 10 of 10 Items |
|